Mechanisms of dendritic cell lysosomal killing of cryptococcus

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Hole, Camaron R ^a   Bui, Hoang ^a   Wormley, Floyd L ^a   Wozniak, Karen L ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CATHEPSIN B; CELL EXTRACT; PROTEINASE INHIBITOR;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW CELL; CELL WALL; CRYPTOCOCCUS NEOFORMANS; CYTOLOGY; DENDRITIC CELL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; LYSOSOME; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; MOUSE; OSMOSIS; REPRODUCIBILITY; ULTRASTRUCTURE;

ANIMALS; ANTIFUNGAL AGENTS; BONE MARROW CELLS; CATHEPSIN B; CELL EXTRACTS; CELL WALL; CRYPTOCOCCUS NEOFORMANS; DENDRITIC CELLS; FEMALE; HUMANS; LYSOSOMES; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; OSMOSIS; PROTEASE INHIBITORS; REPRODUCIBILITY OF RESULTS;

EID: 84868286557     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00739     Document Type: Article

References (46)

1. Levitz, S. M. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 13, 1163-1169 (1991).
2. Mitchell, T. G. & Perfect, J. R. Cryptococcosis in the Era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 8, 515-548 (1995).
3. Park, B. J. et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23, 525-530 (2009).
4. Pappas, P. G. et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 50, 1101-1111, DOI:10.1086/651262 (2010).
5. Powderly, W. G. Cryptococcal Meningitis and AIDS. Clinical Infectious Diseases 17, 837-842 (1993). (Pubitemid 23321900)
6. Huffnagle, G. B., Yates, J. L. & Lipscomb, M. F. T-cell-mediated immunity in the lung-a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude-mice. Infect Immun 59, 1423-1433 (1991).
7. 1 T-Cells. J Exp Med 173, 755-758 (1991).
8. Huffnagle, G. B., Lipscomb, M. F., Lovchik, J. A., Hoag, K. A. & Street, N. E. The role of CD4(1) and CD8(1) T-Cellsin the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol 55, 35-42 (1994). (Pubitemid 24039583)
9. Mody, C. H., Lipscomb, M. F., Street, N. E. & Toews, G. B. Depletion of CD41 (L3T41) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J Immunol 144, 1472-1477 (1990). (Pubitemid 20072924)
10. Murphy, J. W. Protective cell-mediated immunity against Cryptococcus neoformans. Res Immunol 149, 373-386 (1998). (Pubitemid 28372454)
11. Wozniak, K. L. et al. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS One 4 (2009).
12. Steinman, R. M. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation. Mt Sinai J Med 68, 160-166 (2001). (Pubitemid 33606184)
13. Kubach, J. et al. Dendritic cells: sentinels of immunity and tolerance. Int J Hematol 81, 197-203 (2005). (Pubitemid 41364484)
14. Iwasaki, A. Mucosal dendritic cells. Annu Rev Immunol 25, 381-418 (2007). (Pubitemid 46697912)
15. Banchereau, J. et al. Immunobiology of dendritic cells. Annu Rev Immunol 18, 767-811 (2000). (Pubitemid 30365397)
16. Mellman, I. Antigen processing and presentation by dendritic cells: Cell biological mechanisms. Adv Exp Med Biol 560, 63-67 (2005).
17. Mambula, S. S., Simons, E. R., Hastey, R., Selsted, M. E. & Levitz, S. M. Human neutrophil-mediated nonoxidative antifungal activity against Cryptococcus neoformans. Infect Immun 68, 6257-6264 (2000).
18. Newman, S. L. & Holly, A. Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells. Infect Immun 69 (2001).
19. Gildea, L. A., Ciraolo, G. M., Morris, R. E. & Newman, S. L. Human dendritic cell activity against Histoplasma capsulatum is mediated via phagolysosomal fusion. Infect Immun 73, 6803-6811 (2005). (Pubitemid 41368847)
20. Wozniak, K.L. & Levitz, S.M. Cryptococcus neoformans enters the endolysosomal pathway of dendritic cells and is killed by lysosomal components. Infect Immun 76, 4764-4771 (2008).
21. Bozza, S. et al. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J Immunol 168, 1362-1371 (2002). (Pubitemid 34094507)
22. LeBlanc, D. M., Barousse, M. M. & Fidel, P. L., Jr. Role for Dendritic Cells in Immunoregulation during Experimental Vaginal Candidiasis. Infect. Immun. 74, 3213-3221 (2006). (Pubitemid 43794509)
23. Kelly, R. M., Chen, J. M., Yauch, L. E. & Levitz, S. M. Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans. Infect Immun 73, 592-598 (2005). (Pubitemid 40041154)
24. Wozniak, K. L., Vyas, J. M. & Levitz, S. M. In Vivo Role of Dendritic Cells in a Murine Model of Pulmonary Cryptococcosis. Infect. Immun. 74, 3817-3824 (2006). (Pubitemid 43993312)
25. Colbert, J. D., Matthews, S. P., Miller, G. & Watts, C. Diverse regulatory roles for lysosomal proteases in the immune response. Eur J Immunol 39, 2955-2965 (2009).
26. Honey, K. & Rudensky, A. Y. Lysosomal cysteine proteases regulate antigen presentation. Nat Rev Immunol 3, 472-482 (2003). (Pubitemid 37339187)
27. Zavasnik-Bergant, T. & Turk, B. Cysteine cathepsins in the immune response. Tissue Antigens 67, 349-355 (2006).
28. Riese, R. J. & Chapman, H. A. Cathepsins and compartmentalization in antigen presentation. Curr Opin Immunol 12, 107-113 (2000). (Pubitemid 30093458)
29. Lennon-Dumenil, A. M. et al. Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation. J Exp Med 196, 529-540 (2002).
30. Savina, A. & Amigorena, S. Phagocytosis and antigen presentation in dendritic cells. Immunol Rev 219, 143-156 (2007). (Pubitemid 47390005)
31. Illy, C. et al. Role of the occluding loop in cathepsin B activity. J Biol Chem 272, 1197-1202 (1997). (Pubitemid 27034617)
32. Guncar, G. et al. Crystal structure of porcine cathepsin H determined at 2.1 A resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function. Structure 6, 51-61 (1998). (Pubitemid 28084399)
33. Giuliani, A., Pirri, G. & Nicoletto, S. Antimicrobial peptides: An overview of a promising class of therapeutics. Central European Journal of Biology 2, 1-33 (2007). (Pubitemid 46450753)
34. Fjell, C. D., Hiss, J. A., Hancock, R. E. & Schneider, G. Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 11, 37-51 (2012).
35. Peters, B. M., Shirtliff, M. E. & Jabra-Rizk, M. A. Antimicrobial peptides: primeval molecules or future drugs? PLoS Pathog 6 (2010).
36. Trombetta, E. S., Ebersold, M., Garrett, W., Pypaert, M. & Mellman, I. Activation of lysosomal function during dendritic cell maturation. Science 299, 1400-1403 (2003). (Pubitemid 36254654)
37. Trombetta, E. S. & Mellman, I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23, 975-1028 (2005). (Pubitemid 40563191)
38. Premzl, A., Turk, V. & Kos, J. Intracellular proteolytic activity of cathepsin B is associated with capillary-like tube formation by endothelial cells in vitro. J Cell Biochem 97, 1230-1240 (2006).
39. Werle, B., Julke, B., Lah, T., Spiess, E. & Ebert, W. Cathepsin B fraction active at physiological pH of 7.5is of prognostic significance in squamous cell carcinoma of human lung. Br J Cancer 75, 1137-1143 (1997). (Pubitemid 27140024)
40. Tanaka, Y., Tanaka, R., Kawabata, T., Noguchi, Y. & Himeno, M. Lysosomal cysteine protease, cathepsin B, is targeted to lysosomes by the mannose 6-phosphate-independent pathway in rat hepatocytes: site-specific phosphorylation in oligosaccharides of the proregion. J Biochem 128, 39-48 (2000). (Pubitemid 30485367)
41. Ibrahim-Granet, O. et al. Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages. Infect Immun 71, 891-903 (2003). (Pubitemid 36150785)
42. Nicola, A. M. & Casadevall, A. In vitro measurement of phagocytosis and killing of Cryptococcus neoformans by macrophages. Methods Mol Biol 844, 189-197 (2012).
43. Gomez, F. J., Pilcher-Roberts, R., Alborzi, A. & Newman, S. L. Histoplasma capsulatum cyclophilin A mediates attachment to dendritic cell VLA-5. J Immunol 181, 7106-7114 (2008).
44. Feldmesser, M., Kress, Y., Novikoff, P. & Casadevall, A. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun 68, 4225-4237 (2000). (Pubitemid 30434578)
45. Benincasa, M. et al. Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J Antimicrob Chemother 58, 950-959 (2006).
46. Lutz, M. B. et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223, 77-92 (1999). (Pubitemid 29096240)